Propranolol Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Propranolol General Information

Description

Provider of pharmaceutical products. The company provides generic propranolol hydrochloride extended release capsules used to treat hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Catalent
Primary Office
  • 909 Third Avenue
  • New York, NY 10022
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Propranolol Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Propranolol‘s full profile, request access.

Request a free trial

Propranolol Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Propranolol‘s full profile, request access.

Request a free trial